These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 24631738

  • 1. Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).
    Girmenia C, Raiola AM, Piciocchi A, Algarotti A, Stanzani M, Cudillo L, Pecoraro C, Guidi S, Iori AP, Montante B, Chiusolo P, Lanino E, Carella AM, Zucchetti E, Bruno B, Irrera G, Patriarca F, Baronciani D, Musso M, Prete A, Risitano AM, Russo D, Mordini N, Pastore D, Vacca A, Onida F, Falcioni S, Pisapia G, Milone G, Vallisa D, Olivieri A, Bonini A, Castagnola E, Sica S, Majolino I, Bosi A, Busca A, Arcese W, Bandini G, Bacigalupo A, Rambaldi A, Locasciulli A.
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):872-80. PubMed ID: 24631738
    [Abstract] [Full Text] [Related]

  • 2. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
    Choi JK, Cho SY, Yoon SS, Moon JH, Kim SH, Lee JH, Kim JS, Cheong JW, Jang JH, Seo BJ, Kim YJ, Lee HJ, Lee J, Lee JW, Lee DG.
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492
    [Abstract] [Full Text] [Related]

  • 3. Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO).
    Girmenia C, Barosi G, Piciocchi A, Arcese W, Aversa F, Bacigalupo A, Bandini G, Bosi A, Busca A, Castagnola E, Caselli D, Cesaro S, Ciceri F, Locasciulli A, Locatelli F, Mikulska M, Pagano L, Prete A, Raiola AM, Rambaldi A.
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1080-8. PubMed ID: 24582783
    [Abstract] [Full Text] [Related]

  • 4. Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation.
    Sun Y, Xu L, Liu D, Zhang X, Han W, Wang Y, Chen H, Chen Y, Wang F, Wang J, Ji Y, Tang F, Liu K, Huang XJ.
    Clin Microbiol Infect; 2013 Nov; 19(11):1029-34. PubMed ID: 23565830
    [Abstract] [Full Text] [Related]

  • 5. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y, Meng F, Han M, Zhang X, Yu L, Huang H, Wu D, Ren H, Wang C, Shen Z, Ji Y, Huang X.
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [Abstract] [Full Text] [Related]

  • 6. Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial.
    Falda M, Busca A, Baldi I, Mordini N, Bruno B, Allione B, Rambaldi A, Morello E, Narni F, Santarone S, Locatelli F, Bacigalupo A, Gruppo Italiano Trapianto Midollo Osseo (GITMO).
    Am J Hematol; 2007 Oct; 82(10):863-6. PubMed ID: 17616972
    [Abstract] [Full Text] [Related]

  • 7. Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Girmenia C, Barosi G, Aversa F, Bacigalupo A, Barbui T, Baronciani D, Bosi A, Candoni A, Locasciulli A, Locatelli F, Menichetti F, Musso M, Viscoli C, Rambaldi A.
    Clin Infect Dis; 2009 Oct 15; 49(8):1226-36. PubMed ID: 19772390
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience.
    Omer AK, Ziakas PD, Anagnostou T, Coughlin E, Kourkoumpetis T, McAfee SL, Dey BR, Attar E, Chen YB, Spitzer TR, Mylonakis E, Ballen KK.
    Biol Blood Marrow Transplant; 2013 Aug 15; 19(8):1190-6. PubMed ID: 23747459
    [Abstract] [Full Text] [Related]

  • 9. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Patriarca F, Bacigalupo A, Sperotto A, Isola M, Soldano F, Bruno B, van Lint MT, Iori AP, Santarone S, Porretto F, Pioltelli P, Visani G, Iacopino P, Fanin R, Bosi A, GITMO.
    Haematologica; 2008 Oct 15; 93(10):1514-22. PubMed ID: 18728030
    [Abstract] [Full Text] [Related]

  • 10. [The clinical characteristic and risk factors for the incidence of invasive fungal infection in patients following allogeneic hematopoietic stem cell transplantation].
    Zhang Y, Liu C, Liu QF, Sun J, Fan ZP, Xu D, Jiang QL.
    Zhonghua Yi Xue Za Zhi; 2009 Nov 03; 89(40):2814-7. PubMed ID: 20137659
    [Abstract] [Full Text] [Related]

  • 11. Role of acute graft-versus-host disease in the risk of bacteremia and invasive fungal disease after allogeneic hemopoietic stem cell transplantation in children. Results from a single-center observational study.
    Castagnola E, Bagnasco F, Bandettini R, Caviglia I, Morreale G, Lanino E, Giardino S, Moroni C, Haupt R, Faraci M.
    Biol Blood Marrow Transplant; 2014 Jul 03; 20(7):1068-73. PubMed ID: 24691219
    [Abstract] [Full Text] [Related]

  • 12. Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO).
    Dini G, Cancedda R, Giorgiani G, Porta F, Messina C, Uderzo C, Pession A, Fagioli F, La Nasa G, Arcese W, Pollichieni S, Zecca M, Lanino E, Mazzolari E, Cesaro S, Balduzzi A, Rondelli R, Vassallo E, Cappelli B, Locatelli F, Association Italiana Ematologia e Oncologia Pediatrica and Gruppo Italiano per il Trapianto Midollo Osseo.
    Haematologica; 2002 Aug 03; 87(8 Suppl):51-7. PubMed ID: 12412391
    [Abstract] [Full Text] [Related]

  • 13. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.
    Rigacci L, Puccini B, Dodero A, Iacopino P, Castagna L, Bramanti S, Ciceri F, Fanin R, Rambaldi A, Falda M, Milone G, Guidi S, Martelli MF, Mazza P, Oneto R, Bosi A, Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Ann Hematol; 2012 Jun 03; 91(6):931-9. PubMed ID: 22245922
    [Abstract] [Full Text] [Related]

  • 14. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
    Harrison N, Mitterbauer M, Tobudic S, Kalhs P, Rabitsch W, Greinix H, Burgmann H, Willinger B, Presterl E, Forstner C.
    BMC Infect Dis; 2015 Dec 29; 15():584. PubMed ID: 26715563
    [Abstract] [Full Text] [Related]

  • 15. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X, Wei JL, Huang Y, He Y, Yang DL, Jiang EL, Ma QL, Zhou LK, Lin XT, Shen YY, Feng SZ, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug 29; 33(8):610-4. PubMed ID: 23134851
    [Abstract] [Full Text] [Related]

  • 16. Epidemiology and risk factors for invasive fungal diseases in hematopoietic stem cell transplantation.
    Girmenia C, Ferretti A, Barberi W.
    Curr Opin Hematol; 2014 Nov 29; 21(6):459-65. PubMed ID: 25295743
    [Abstract] [Full Text] [Related]

  • 17. Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Castagnola E, Bagnasco F, Menoni S, Muraca M, Prete A, Belotti T, Iori AP, Barberi W, Severino A, Proia A, Raiola AM, Vacca A, Cudillo L, Rambaldi A, Girmenia C.
    Bone Marrow Transplant; 2018 Sep 29; 53(9):1193-1197. PubMed ID: 29563591
    [No Abstract] [Full Text] [Related]

  • 18. [Impact of HLA compatibility on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia].
    ZHANG Y, CHEN YK, FAN ZP, XU D, JIANG QL, SUN J, LIU QF.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar 29; 31(3):438-42. PubMed ID: 21421478
    [Abstract] [Full Text] [Related]

  • 19. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H, Lan-Ping X, Kai-Yan L, Dai-Hong L, Huan C, Wei H, Yu-Hong C, Jing-Zhi W, Yao C, Xiao-Hui Z, Hong-Xia S, Dao-Pei L.
    Ann Med; 2008 Mar 29; 40(6):444-55. PubMed ID: 18608121
    [Abstract] [Full Text] [Related]

  • 20. Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of AIEOP-GITMO.
    Dufour C, Rondelli R, Locatelli F, Miano M, Di Girolamo G, Bacigalupo A, Messina C, Porta F, Balduzzi A, Iorio AP, Buket E, Madon E, Pession A, Dini G, Di Bartolomeo P, Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP), Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Br J Haematol; 2001 Mar 29; 112(3):796-805. PubMed ID: 11260086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.